Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Patoulias D, Katsimardou A, Imprialos K, Stavropoulos K, et al. GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS DO NOT DECREASE THE RISK FOR CORONARY REVASCULARIZATION IN PATIENTS WITH TYPE 2 DIABETES: A META-ANALYSIS OF CARDIOVASCULAR OUTCOME TRIALS. J Hypertens 2022;40.
PMID: 36027008


Privacy Policy